However, some cutting-edge technologies like PROTACs (proteolysis-targeting chimeras), RNA interference, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-based genome editing, and artificial intelligence (AI)-based drug design, allow screening of therapeutics targeting almost all kinds of molecules, like proteins and epigenetic regulators
Epub 2012 Sep 23
Presented for research literature review only Zadziski R et al
"In the case of fermentation-based active substances, which consist of more than one active moiety, the impurity profile is usually very complex and the thresholds in the ICH Q3A and Q3B cannot be considered applicable," said Xellia
A 2025 systematic review of 544 records found 35 preclinical and 1 clinical study, with no clinical safety data
Always use fresh sterile supplies for each reconstitution and each dose drawing session